【4886】あすか製薬ホールディングス

医薬品、医薬部外品、食品、動物用医薬品、飼料および飼料添加物、医療機器等の製造・販売ならびに輸出入、臨床検査・試験業務等を営む子会社等の経営管理およびこれに附帯する業務

類似企業：

【業界1位】小野薬品工業

【売上同水準】科研製薬 扶桑薬品工業

東証プライム

医薬品医薬

＞

その他医療・医薬品医他

売上高

営業利益

経常利益

当期利益

決算期	日付	予・実	売上高 (百万円)	対前回	修正率	修正率	営業利益 (百万円)	対前回	修正率	修正率	経常利益 (百万円)	対前回	修正率	修正率	当期利益 (百万円)	対前回	修正率	修正率
2027.03	2026/08/04	Q1予	73,000	→	0.0%	0.0%	6,200	→	0.0%	0.0%	6,100	→	0.0%	0.0%	4,800	→	0.0%	0.0%
2027.03	2026/05/11	当初予	73,000	-	-	-	6,200	-	-	-	6,100	-	-	-	4,800	-	-	-
2026.03	2026/05/11	実	71,127	↑	+0.2%	-5.2%	5,834	↓	-2.8%	-14.2%	5,665	↓	-5.6%	-16.7%	5,424	↑	+8.5%	+4.3%
2026.03	2026/02/02	Q3予	71,000	→	0.0%	-5.3%	6,000	→	0.0%	-11.8%	6,000	→	0.0%	-11.8%	5,000	→	0.0%	-3.8%
2026.03	2025/11/04	Q2予	71,000	↓	-5.3%	-5.3%	6,000	↓	-11.8%	-11.8%	6,000	↓	-11.8%	-11.8%	5,000	↓	-3.8%	-3.8%
2026.03	2025/08/04	Q1予	75,000	→	0.0%	0.0%	6,800	→	0.0%	0.0%	6,800	→	0.0%	0.0%	5,200	→	0.0%	0.0%
2026.03	2025/05/12	当初予	75,000	-	-	-	6,800	-	-	-	6,800	-	-	-	5,200	-	-	-
2025.03	2025/05/12	実	64,139	↑	+1.8%	+1.8%	5,331	↓	-20.4%	-20.4%	5,107	↓	-23.8%	-23.8%	5,101	↑	+2.0%	+2.0%
2025.03	2025/02/03	Q3予	63,000	→	0.0%	0.0%	6,700	→	0.0%	0.0%	6,700	→	0.0%	0.0%	5,000	→	0.0%	0.0%
2025.03	2024/11/05	Q2予	63,000	→	0.0%	0.0%	6,700	→	0.0%	0.0%	6,700	→	0.0%	0.0%	5,000	→	0.0%	0.0%
2025.03	2024/08/05	Q1予	63,000	→	0.0%	0.0%	6,700	→	0.0%	0.0%	6,700	→	0.0%	0.0%	5,000	→	0.0%	0.0%
2025.03	2024/05/10	当初予	63,000	-	-	-	6,700	-	-	-	6,700	-	-	-	5,000	-	-	-
2024.03	2024/05/10	実	62,843	↑	+1.4%	+1.4%	6,500	↑	+20.4%	+20.4%	6,522	↑	+18.6%	+18.6%	7,545	↑	+21.7%	+71.5%
2024.03	2024/02/05	Q3予	62,000	→	0.0%	0.0%	5,400	→	0.0%	0.0%	5,500	→	0.0%	0.0%	6,200	→	0.0%	+40.9%
2024.03	2023/11/06	Q2予	62,000	→	0.0%	0.0%	5,400	→	0.0%	0.0%	5,500	→	0.0%	0.0%	6,200	→	0.0%	+40.9%
2024.03	2023/09/25	修正予	62,000	→	0.0%	0.0%	5,400	→	0.0%	0.0%	5,500	→	0.0%	0.0%	6,200	↑	+40.9%	+40.9%
2024.03	2023/08/07	Q1予	62,000	→	0.0%	0.0%	5,400	→	0.0%	0.0%	5,500	→	0.0%	0.0%	4,400	→	0.0%	0.0%
2024.03	2023/05/11	当初予	62,000	-	-	-	5,400	-	-	-	5,500	-	-	-	4,400	-	-	-
2023.03	2023/05/11	実	60,461	↑	+0.8%	+5.1%	5,108	↓	-1.8%	+21.6%	5,232	↓	-1.3%	+21.7%	4,238	↑	+0.9%	+28.4%
2023.03	2023/02/06	Q3予	60,000	→	0.0%	+4.3%	5,200	→	0.0%	+23.8%	5,300	→	0.0%	+23.3%	4,200	→	0.0%	+27.3%
2023.03	2022/11/07	Q2予	60,000	↑	+4.3%	+4.3%	5,200	↑	+23.8%	+23.8%	5,300	↑	+23.3%	+23.3%	4,200	↑	+27.3%	+27.3%
2023.03	2022/08/08	Q1予	57,500	→	0.0%	0.0%	4,200	→	0.0%	0.0%	4,300	→	0.0%	0.0%	3,300	→	0.0%	0.0%
2023.03	2022/05/12	当初予	57,500	-	-	-	4,200	-	-	-	4,300	-	-	-	3,300	-	-	-
2022.03	2022/05/12	実	56,607	↓	-0.7%	+8.9%	4,795	↑	+6.6%	+219.7%	4,880	↑	+8.4%	+225.3%	4,290	↑	+43.0%	+436.3%
2022.03	2022/03/28	修正予	57,000	↑	+3.6%	+9.6%	4,500	↑	+28.6%	+200.0%	4,500	↑	+25.0%	+200.0%	-	-	-	-
2022.03	2022/02/07	Q3予	55,000	→	0.0%	+5.8%	3,500	→	0.0%	+133.3%	3,600	↑	+2.9%	+140.0%	3,000	↑	+215.4%	+275.0%
2022.03	2021/12/20	修正予	55,000	↑	+0.9%	+5.8%	3,500	→	0.0%	+133.3%	3,500	↓	-2.8%	+133.3%	-	-	-	-
2022.03	2021/11/01	Q2予	54,500	→	0.0%	+4.8%	3,500	→	0.0%	+133.3%	3,600	↑	+2.9%	+140.0%	-2,600	↓	-425.0%	-425.0%
2022.03	2021/09/27	修正予	54,500	↑	+4.8%	+4.8%	3,500	↑	+133.3%	+133.3%	3,500	↑	+133.3%	+133.3%	-	-	-	-
2022.03	2021/08/02	Q1予	52,000	-	-	-	1,500	-	-	-	1,500	-	-	-	800	-	-	-
2021.03	2021/04/23	当初予	55,100	-	-	-	-	-	-	-	3,000	-	-	-	-	-	-	-